Standout Papers

Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration 2006 2026 2012 2019 942
  1. Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration (2006)
    Robert L. Avery, Dante J. Pieramici et al. Ophthalmology
  2. Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy (2006)
    Robert L. Avery, Joel Pearlman et al. Ophthalmology

Immediate Impact

1 by Nobel laureates 1 from Science/Nature 72 standout
Sub-graph 1 of 21

Citing Papers

Age-Related Macular Degeneration
2024 Standout
Diabetes mellitus—Progress and opportunities in the evolving epidemic
2024 Standout
4 intermediate papers

Works of Matthew Giust being referenced

Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy
2006 Standout
Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration
2006 Standout

Author Peers

Author Last Decade Papers Cites
Matthew Giust 1365 1120 272 3 1.5k
Andrea Rivera 1186 694 2 796 8 1.4k
Bernd Sommerauer 1672 1384 17 329 8 2.1k
Eiichi Sekiyama 828 740 4 665 14 1.4k
Jacqueline J.M. Assink 1100 825 1 301 8 1.3k
R.S. Ramrattan 1185 849 1 196 7 1.4k
Michelle K. Staples 1007 544 957 8 1.8k
Ida Dielemans 1970 1435 1 270 8 2.1k
Ortrud Gerstner 1304 1108 4 129 5 1.4k
Hadassah Gnessin 1187 849 2 907 10 1.9k
Harry A. Quigley 1940 1242 1 309 16 2.1k

All Works

Loading papers...

Rankless by CCL
2026